GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Gallbladder and Pancreas/Selective Use of Biliary Drainage Supported in pCCA : BJS | Jun 2026
19

Selective Use of Biliary Drainage Supported in pCCA : BJS | Jun 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated June 1, 2026

Introduction:

Preoperative biliary drainage (PBD) is frequently used in patients with perihilar cholangiocarcinoma (pCCA) to relieve biliary obstruction before surgery. The proposed benefits include improved liver function, reduced jaundice, and optimization of the future liver remnant before major hepatectomy. However, biliary drainage is also associated with procedure-related complications, infection, and potential delays to definitive surgery. As a result, its routine use remains controversial.

Problem Statement:

Current practice varies widely because there is no clear consensus regarding which patients with resectable pCCA truly benefit from preoperative biliary drainage. Determining whether drainage improves or worsens postoperative outcomes is critical for optimizing perioperative management and reducing surgical risk.

Summary:

This large international multicenter study evaluated the impact of preoperative biliary drainage on postoperative outcomes in patients undergoing resection for perihilar cholangiocarcinoma. After adjustment for important baseline differences, the investigators found that patients who underwent biliary drainage experienced higher rates of major postoperative complications and, most notably, a significantly increased risk of posthepatectomy liver failure. When additional multivariable analyses were performed, the association with posthepatectomy liver failure remained robust, suggesting that biliary drainage may contribute to adverse postoperative liver-related outcomes in selected patients. These findings challenge the traditional assumption that preoperative drainage is universally beneficial before major liver resection for pCCA. Importantly, the study does not imply that biliary drainage should be abandoned altogether. Rather, it highlights that a subset of patients with resectable disease may proceed safely to surgery without routine drainage. The results support a more individualized approach in which decisions are guided by factors such as bilirubin levels, cholangitis, anticipated future liver remnant volume, and planned extent of resection. Given the retrospective nature of the analysis, definitive conclusions regarding causality cannot be drawn. Nevertheless, this represents one of the largest studies addressing this question and provides important evidence that routine preoperative biliary drainage should be carefully reconsidered. Future prospective studies are needed to better define which patients derive genuine benefit from drainage before surgery for perihilar cholangiocarcinoma.

Related Q&A

20

Pancreatic Plasticity in Development and Disease : Nat Rev Gastroenterol Hepatol | May 2026

Introduction The pancreas represents one of the most dynamic models of cellular plasticity in human biology, where developmental fate decisions, tissue maintenance and regenerative responses are orchestrated through...

21

Rethinking Antibiotic Strategy in Infected Necrotizing Pancreatitis | Journal of Antimicrobial Chemotherapy

Introduction Infected necrotizing pancreatitis remains one of the most severe complications of acute pancreatitis and is associated with substantial morbidity, organ failure and mortality. Management relies on timely...

22

GCAL Score Helps Triage EUS in Unexplained Bile Duct Dilatation | Indian Journal of Gastroenterology

Introduction Unexplained common bile duct (CBD) dilatation is a frequent and often challenging clinical finding in gastroenterology practice. Although cross-sectional imaging may fail to identify a cause, endoscopic...

23

SPINK1 p.Asn34Ser: Gastroenterology | May 2026

Introduction The SPINK1 gene encodes the pancreatic secretory trypsin inhibitor, a key protective molecule that prevents premature trypsin activation within the pancreas. Dysfunction of this pathway is central...

24

Rome V Gallbladder and Sphincter of Oddi Disorders: Gastroenterology | May 2026

The Rome V Gallbladder and Sphincter of Oddi Disorders chapter substantially modernizes this field by moving away from historically overused functional labels and procedure-driven diagnosis toward a more...

25

Optimal Timing of Endoscopic Necrosectomy After Catheter Drainage: Gastroenterology/ May 2026

Introduction Management of necrotising pancreatitis has evolved toward a minimally invasive, step-up approach, where initial catheter drainage—either percutaneous or endoscopic—is followed by endoscopic necrosectomy only when required. A...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer